Try our beta test site

Single Rising Dose Study of BI 655066 in Patients With Moderate and Severe Psoriasis

This study has been completed.
Sponsor:
Collaborator:
Boehringer Ingelheim
Information provided by (Responsible Party):
AbbVie
ClinicalTrials.gov Identifier:
NCT01577550
First received: April 10, 2012
Last updated: November 15, 2016
Last verified: November 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2014
  Primary Completion Date: October 2013 (Final data collection date for primary outcome measure)